Fostamatinib is taken by mouth as a tablet, usually twice a day. It can be taken with or without food. It’s important to take your doses about 12 hours apart to keep a steady level of the medicine in your body. Swallow the tablet whole; do not crush, cut, or chew it. Your doctor will determine your starting dose and may adjust it over time based on your platelet count and how well you tolerate the medication. It’s crucial to take Fostamatinib regularly as prescribed, even if you don’t feel immediate changes, as its goal is to manage your platelet count over time.
Fostamatinib works by blocking a specific enzyme inside certain immune cells called spleen tyrosine kinase (SYK). In chronic ITP, the immune system creates antibodies that attach to platelets, marking them for destruction. These marked platelets are then typically destroyed in the spleen by specialized immune cells (macrophages) that use the SYK pathway. By inhibiting SYK, Fostamatinib interferes with the process by which these immune cells destroy platelets. This helps to reduce the destruction of platelets and allows platelet counts to increase, which lowers the risk of bleeding in patients with ITP.
Like all medications, Fostamatinib can cause side effects. Common ones include:
- Diarrhea: This is a very common side effect and can sometimes be severe.
- Nausea, vomiting, stomach pain: Digestive issues are frequent.
- High blood pressure (hypertension): Your blood pressure will need to be monitored regularly.
- Dizziness: Some people may feel lightheaded.
- Liver enzyme elevations: Blood tests will be done to check your liver function.
- Rash: Skin rashes can occur.
More serious but less common side effects can include severe diarrhea, elevated blood pressure that is difficult to control, and changes in liver function. It can also rarely cause neutropenia (low white blood cell count). Your doctor will monitor you with regular blood tests and blood pressure checks. Report any new or worsening symptoms to your doctor immediately.
Before taking Fostamatinib, your doctor will carefully review your medical history, especially if you have:
- High blood pressure: Your blood pressure must be well-controlled before starting Fostamatinib and monitored regularly during treatment, as it can cause or worsen hypertension.
- Liver problems: Fostamatinib can affect liver enzymes, so if you have existing liver disease, your doctor will monitor you closely.
- History of blood clots: Although not a direct warning, ITP patients may have varying risks.
- Neutropenia (low white blood cell count): Your white blood cell count will be monitored, as Fostamatinib can sometimes lower it further.
- Pregnancy and breastfeeding: Fostamatinib can harm an unborn baby. Effective contraception should be used during treatment and for at least one month after the last dose. It is not known if it passes into breast milk, so breastfeeding is not recommended.
It is very important to tell your doctor about all other medicines you are taking, including over-the-counter drugs, vitamins, and herbal supplements, as Fostamatinib can interact with many of them.
- Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): These can significantly increase the levels of Fostamatinib in your body, increasing the risk of side effects. Your doctor may need to reduce your Fostamatinib dose.
- Strong CYP3A4 inducers (e.g., rifampin, St. John’s Wort): These can decrease the levels of Fostamatinib, making it less effective. This combination should generally be avoided.
- P-glycoprotein substrates (e.g., digoxin): Fostamatinib can increase the levels of drugs that are transported by P-glycoprotein, potentially leading to more side effects from those drugs.
- Warfarin: Fostamatinib can affect the blood-thinning effects of warfarin, requiring careful monitoring of blood clotting.
- Statins (for cholesterol): Fostamatinib can increase the levels of some statins, increasing the risk of muscle problems.
Always provide a complete medication list to your healthcare provider to prevent dangerous interactions.
The dosage of Fostamatinib is individualized for each patient with chronic immune thrombocytopenia.
- Initial Dose: The usual starting dose for adults is 100 mg taken orally twice a day.
- Dose Adjustment: Your doctor will monitor your platelet count closely, typically every two to four weeks. If your platelet count does not increase enough after a few weeks at the initial dose, or if you tolerate the medication well, your doctor may increase the dose to 150 mg twice a day.
- Maximum Dose: The maximum recommended dose is 150 mg twice a day.
- Monitoring: Regular blood tests (including platelet counts, complete blood counts, and liver function tests) and blood pressure monitoring are essential throughout your treatment to ensure the medication is working and to manage any side effects.
Do not adjust your dose without speaking to your doctor.
Fostamatinib is a prescription-only medication due to its specialized use in a rare blood disorder and the need for close medical supervision. You cannot obtain it without a valid prescription. The prescription process involves:
- Diagnosis of Chronic ITP: A definitive diagnosis of chronic immune thrombocytopenia in adults, particularly when other treatments have failed, is required. This involves specific blood tests to confirm low platelet counts and rule out other causes.
- Specialist Care: Fostamatinib is typically prescribed and managed by hematologists (blood disorder specialists) or oncologists who have experience in treating ITP.
- Comprehensive Evaluation: Your doctor will conduct a thorough medical evaluation, including a review of your medical history, other medications, and blood pressure, to ensure Fostamatinib is safe and appropriate for your condition.
- Ongoing Monitoring Plan: Due to potential side effects like high blood pressure, diarrhea, and changes in blood counts or liver function, a strict monitoring plan with regular follow-up appointments and blood tests is essential.
Therefore, Fostamatinib is prescribed and managed under the strict supervision of a qualified healthcare professional to ensure effective and safe treatment.
What is Fostamatinib used for? Treatment of chronic immune thrombocytopenia (ITP) in adults
2. What is the active ingredient? Fostamatinib disodium hexahydrate
3. What drug class does it belong to? Kinase inhibitor (SYK inhibitor)
4. Is it a controlled substance? No
5. Is it available in generic form? No
6. How is Fostamatinib administered? Orally, as tablets
7. What strengths are available? 100 mg and 150 mg tablets
8. What is the usual adult dosage? Start with 100 mg twice daily; may increase to 150 mg twice daily after 4 weeks if needed
9. Can it be used in children? Not approved for pediatric use
10. What are common side effects? Diarrhea, hypertension, dizziness, nausea, liver enzyme elevation
11. Can it cause serious reactions? Yes—hepatotoxicity, severe hypertension, neutropenia
12. Is it safe during pregnancy? Not recommended; may harm the fetus
13. Is a prescription required? Yes
14. Is Fostamatinib available in Pakistan? Only via specialty import programs
15. How should it be taken? With or without food, twice daily
16. What precautions should be taken during use? Monitor blood pressure, liver function, and complete blood counts
17. What are contraindications? Hypersensitivity to fostamatinib or its components
18. What monitoring is needed during use? Platelet counts, liver enzymes, blood pressure
19. Can it be combined with other ITP treatments? Yes—sometimes used after corticosteroids, rituximab, or thrombopoietin receptor agonists
20. What are similar drugs? Eltrombopag, romiplostim (TPO receptor agonists), rituximab